Pulike Biological Engineering

Pulike Biological Engineering EPS

The Earnings per Share (EPS) of Pulike Biological Engineering (603566.SS) as of Nov 2, 2026 is 0.54 CNY. In the previous year, Earnings per Share (EPS) was 0.27 CNY — a change of 102.31% (higher).

EPS

0.54CNY

YoY

102.31%

Last updated:

Earnings per Share (EPS) of Pulike Biological Engineering is 2025 0.54 CNY. Earnings per Share (EPS) of Pulike Biological Engineering was 2024 0.27 CNY. It decreases by 102.31% higher compared to the previous year.

The Pulike Biological Engineering EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
0.80 CNY
Jan 1, 2022
0.47 CNY
Jan 1, 2023
0.48 CNY
Jan 1, 2024
0.27 CNY
Jan 1, 2025
0.54 CNY
Jan 1, 2026 (e)
0.47 CNY
Jan 1, 2027 (e)
0.51 CNY
Jan 1, 2028 (e)
0.67 CNY
The Pulike Biological Engineering EPS history
YEAREPSYoY
est0.67CNY+31.37%
est0.51CNY+8.51%
est0.47CNY-13.27%
0.54CNY+102.31%
0.27CNY-44.31%
0.48CNY+1.27%
0.47CNY-40.82%
0.80CNY+19.02%
0.67CNY+106.51%
0.33CNY-21.51%
0.42CNY+13.91%
0.37CNY-38.18%
0.59CNY+41.53%
0.42CNY-28.14%
0.58CNY+21.76%
0.48CNY+26.04%
0.38CNY+11.99%
0.34CNY+37.37%
0.25CNY-9.45%
0.27CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc generates revenue through the research, development, manufacturing, and sale of veterinary biological products and chemical medicines. The company produces vaccines and antibodies for preventing and controlling epidemic diseases in poultry and livestock, alongside chemical medicines used in treating such diseases. Its primary customers are animal health providers and agricultural enterprises requiring disease prevention and treatment solutions for poultry and livestock. The business focuses on the veterinary biological products segment, including vaccines and antibodies, and the chemical medicines segment for livestock and poultry health management. The company's product portfolio includes veterinary biological products such as vaccines and antibodies, which are applied in the prevention and control of infectious diseases in poultry and livestock. Chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. Pulike Biological Engineering Inc targets agricultural enterprises and animal health sectors as key market segments, delivering solutions for disease management in the livestock and poultry industries. Pulike Biological Engineering Inc's revenue streams are derived from the sale of veterinary biological products and chemical medicines. The company's veterinary biological products segment encompasses vaccines and antibodies for preventing and controlling infectious diseases in poultry and livestock. Chemical medicines are sold for treating epidemic diseases in the same sectors. The business serves agricultural enterprises and animal health providers seeking comprehensive disease management solutions for poultry and livestock health. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

Earnings per Share (EPS) of Pulike Biological Engineering is 0.54 CNY in 2025.

Earnings per Share (EPS) of Pulike Biological Engineering changed from 0.27 CNY to 0.54 CNY, representing a 102.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Pulike Biological Engineering

All Key Metrics — Pulike Biological Engineering